{"address1": "Generaal De Wittelaan L11 A3", "city": "Mechelen", "zip": "2800", "country": "Belgium", "phone": "32 1 534 29 00", "fax": "32 1 534 29 01", "website": "https://www.glpg.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.\u00e0 r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.", "fullTimeEmployees": 704, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paulus A. Stoffels M.D., Ph.D.", "age": 62, "title": "CEO, Chairman, Interim Head of R&D", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1322987, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thad  Huston C.M.A.", "age": 53, "title": "Executive VP, CFO & COO", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Valeria  Cnossen", "age": 50, "title": "Executive VP & General Counsel", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Marieke  Vermeersch", "title": "Head of Corporate Communication", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Annelies  Missotten", "age": 51, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ellen Van Der Aar", "title": "Head of Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philippe  Alen M.B.A., Ph.D., Pharm.D.", "title": "Senior VP & Head of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alice  Dietrich", "title": "Head of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pierre J.M.B. Raboisson Ph.D., Pharm.D.", "title": "Head of Small Molecules Discovery & Senior VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Patrik  Ringblom", "title": "Head of Strategy & US Lead", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 25.12, "open": 25.25, "dayLow": 24.65, "dayHigh": 25.25, "regularMarketPreviousClose": 25.12, "regularMarketOpen": 25.25, "regularMarketDayLow": 24.65, "regularMarketDayHigh": 25.25, "payoutRatio": 0.0, "beta": -0.006, "forwardPE": -23.817308, "volume": 183572, "regularMarketVolume": 183572, "averageVolume": 260575, "averageVolume10days": 143880, "averageDailyVolume10Day": 143880, "bid": 18.19, "ask": 31.61, "bidSize": 1, "askSize": 1, "marketCap": 1658963328, "fiftyTwoWeekLow": 22.36, "fiftyTwoWeekHigh": 32.17, "priceToSalesTrailing12Months": 6.0183907, "fiftyDayAverage": 25.08, "twoHundredDayAverage": 26.7446, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -1473580544, "profitMargins": 0.26875, "floatShares": 44547738, "sharesOutstanding": 65897100, "sharesShort": 1999848, "sharesShortPriorMonth": 1730367, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.030299999, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.48147, "shortRatio": 8.58, "shortPercentOfFloat": 0.040700004, "impliedSharesOutstanding": 66974700, "bookValue": 43.962, "priceToBook": 0.56344116, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -1282000, "trailingEps": -0.02, "forwardEps": -1.04, "enterpriseToRevenue": -5.346, "enterpriseToEbitda": 9.611, "52WeekChange": -0.22082418, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 24.77, "targetHighPrice": 40.29825, "targetLowPrice": 25.045385, "targetMeanPrice": 31.500107, "targetMedianPrice": 32.89604, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 3117573120, "totalCashPerShare": 47.31, "ebitda": -153319008, "totalDebt": 11722000, "quickRatio": 9.567, "currentRatio": 9.966, "totalRevenue": 275648992, "debtToEquity": 0.405, "revenuePerShare": 0.20915, "returnOnAssets": -0.02754, "returnOnEquity": -0.00045000002, "grossProfits": 240786000, "freeCashflow": -274430752, "operatingCashflow": -320025984, "grossMargins": 0.87351996, "ebitdaMargins": -0.55621, "operatingMargins": -0.81433, "financialCurrency": "EUR", "symbol": "GLPG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Galapagos NV", "longName": "Galapagos NV", "preMarketChange": -0.5, "preMarketChangePercent": -2.018571, "preMarketPrice": 24.27, "regularMarketChange": -0.35000038, "regularMarketDayRange": "24.65 - 25.25", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 260575, "fiftyTwoWeekLowChange": 2.4099998, "fiftyTwoWeekLowChangePercent": 0.107781745, "fiftyTwoWeekRange": "22.36 - 32.17", "fiftyTwoWeekHighChange": -7.3999977, "fiftyTwoWeekHighChangePercent": -0.23002791, "fiftyTwoWeekChangePercent": -22.082418, "earningsTimestamp": 1745405940, "earningsTimestampStart": 1745405940, "earningsTimestampEnd": 1745405940, "earningsCallTimestampStart": 1745492340, "earningsCallTimestampEnd": 1745492340, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.02, "epsForward": -1.04, "epsCurrentYear": -0.54, "priceEpsCurrentYear": -45.87037, "fiftyDayAverageChange": -0.30999947, "fiftyDayAverageChangePercent": -0.012360426, "twoHundredDayAverageChange": -1.9745998, "twoHundredDayAverageChangePercent": -0.07383172, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1330353000000, "regularMarketChangePercent": -1.3933136, "regularMarketPrice": 24.77, "corporateActions": [], "preMarketTime": 1743595509, "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_1716658", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "displayName": "Galapagos", "trailingPegRatio": null}